Every financial statement,
one clean chart.
Search any US-listed company. Data straight from SEC filings.
IDEAYA Biosciences, Inc. (IDYA), most recent 12 months reported: revenue $234.13M, net loss $175.02M, free cash flow -$113.87M. Latest balance sheet on file: liquid cash $828.96M. From SEC filings. More on IDEAYA Biosciences, Inc.: Revenue · Profitability · Cash flow · Debt Others in Pharmaceutical Preparations: Syndax Pharmaceuticals, Inc. · RHYTHM PHARMACEUTICALS, INC. · PHATHOM PHARMACEUTICALS, INC. · ANAPTYSBIO, INC. · PUMA BIOTECHNOLOGY, INC. · AKEBIA THERAPEUTICS, INC. · VANDA PHARMACEUTICALS INC. · Maravai LifeSciences Holdings, Inc.
Filter every US company by the numbers — net cash, margins, ROIC, growth. Looking for one company? The search box above is free.
Follow a company and we'll email you when it files a quarterly or annual report with the SEC. Free follows 3 companies; Pro follows up to 500, and sorts and filters them.